Clincosm LogoSign in Get a demo

Advanced Malignancies

Showing NaN - NaN of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignancies Trial in Beijing (1A46 Drug Substance)

Not yet recruiting
  • Advanced Malignancies
  • 1A46 Drug Substance
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 4, 2023

Advanced Malignancies, Non-small-cell Lung Cancer Trial in Worldwide (PF-06801591)

Active, not recruiting
  • Advanced Malignancies
  • Non-small-cell Lung Cancer
  • Beijing, Beijing, China
  • +51 more
Jan 11, 2023

Advanced Malignancies Trial in Beijing (IBI939, IBI939+ Sintilimab)

Active, not recruiting
  • Advanced Malignancies
  • Beijing, China
    Peking University Cancer Hospital & Institute
Oct 4, 2022

Advanced Malignancies Trial in Beijing (IBI322)

Active, not recruiting
  • Advanced Malignancies
  • IBI322
  • Beijing, China
    Cancer hospital Chinese academy of Medical sciences
Sep 15, 2022

Advanced Malignancies Trial in Beijing (BR105 injection)

Not yet recruiting
  • Advanced Malignancies
  • BR105 injection
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Apr 24, 2022

Advanced Malignancies Trial in Worldwide (Tislelizumab 200 mg, IV, Pamiparib 20, 40, 60 mg PO Twice Daily (BID), Pemetrexed 500

Enrolling by invitation
  • Advanced Malignancies
  • Tislelizumab 200 mg, IV
  • +4 more
  • Miami Beach, Florida
  • +50 more
Mar 4, 2022

Advanced Malignancies Trial in Beijing (Recombinant Humanized Monoclonal Antibody MIL95)

Recruiting
  • Advanced Malignancies
  • Recombinant Humanized Monoclonal Antibody MIL95
  • Beijing, China
    Beijing Cancer Hospital
Feb 14, 2022

Advanced Malignancies Trial in Beijing (Recombinant Humanized Monoclonal Antibody MIL93)

Recruiting
  • Advanced Malignancies
  • Recombinant Humanized Monoclonal Antibody MIL93
  • Beijing, China
    Cancer Hospital,Chinese Academy of Medical Sciences and Peking U
Feb 13, 2022

Advanced Malignancies Trial in Beijing (SHR-1501)

Unknown status
  • Advanced Malignancies
  • Beijing, China
    Cancer hospital, Chinese academy of medical sciences
Jul 21, 2020